Big Pharma keeps pushing for weaker pollution standards despite proven risks to human and environmental health

Despite drug shortages and soaring prices, mainstream academia continues to ignore Public Pharma as a solution

The WHO Executive Board will discuss global health priorities this week, including substandard and falsified medical products, with key implications for public pharmaceutical initiatives

Indonesia’s new patent law has raised alarm over potential barriers to accessing life-saving medicines

Protesters condemn Gilead for prioritizing exorbitant profits over public health, accusing the pharmaceutical company of obstructing widespread generic production of new HIV drug lenacapavir

Pharmacy services in Serbia have become entirely profit-driven, with the needs of the population pushed aside

The high price tag on the HIV drug lenacapavir underscores the widespread dysfunction within Big Pharma

Four years after the onset of COVID-19, children’s vaccination rates are stalling and declining. Armed conflicts and weakening of public health systems are to blame

Nearly three decades after Jonas Salk’s passing, his legacy continues to highlight the need for building a different pharmaceutical industry

An increase in local dengue transmissions reported by EU public health agencies has raised concerns about outbreak risks as climate change makes the region more suitable for Aedes mosquitoes

Negotiations surrounding the Pandemic Treaty continue as the deadline for endorsing the new mechanism approaches. However, the version under discussion fails to address critical issues pertaining to health equity

The Colombian government recently issued a compulsory license for HIV drug dolutegravir, making the treatment more accessible for thousands of people